ArticleMolecular cancer therapeutics2023

AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors.

Weining Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.